| Literature DB >> 18680151 |
Fiona S Anderson1, Alicia S Kunin-Batson.
Abstract
Advances in the treatment of childhood cancers have greatly improved survivorship. Success has not come without cost, however, as survivors are at risk for late effects of treatment, including neurocognitive late effects (e.g., difficulties with thinking and reasoning). In the advent of chemotherapy-only protocols, researchers are examining neurocognitive sequelae of these agents to understand the specific role of chemotherapy in neurocognitive changes and the mechanism through which these occur. In this review, we examine the state of the literature on neurocognitive late effects after chemotherapy and their proposed neural mechanisms. (c) 2008 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2009 PMID: 18680151 DOI: 10.1002/pbc.21700
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167